Stimulation of TIMP-1 production by oncostatin M in human articular cartilage

Arthritis and Rheumatism

Volumn 39, Issue 4, 1996, Pages 560-566

  Nemoto, Osamu ^a   Yamada, Harumoto ^a   Mukaida, Masahiro ^a   Shimmei, Masayuki ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 11; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; MESSENGER RNA; ONCOSTATIN M; TISSUE INHIBITOR OF METALLOPROTEINASE;

ADULT; ARTICLE; ARTICULAR CARTILAGE; AUTOPSY; CARTILAGE CELL; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; OSTEOARTHRITIS; PRIORITY JOURNAL;

ADULT; AMINO ACID SEQUENCE; CARTILAGE, ARTICULAR; CELL DIVISION; CELLS, CULTURED; CYTOKINES; GLYCOPROTEINS; GROWTH SUBSTANCES; HUMANS; METALLOENDOPEPTIDASES; MOLECULAR SEQUENCE DATA; ONCOSTATIN M; PEPTIDES; PROTEASE INHIBITORS; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0029960961     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390404     Document Type: Article

References (42)

1. Ballet AJ, Nance JL: Biochemical findings in normal and osteoarthritic cartilage. II. Chondroitin sulfate concentration and chain length, water and ash content. J Clin Invest 45:1170-1177, 1966
2. Mankin AJ, Lippiello L: The glycosaminoglycans of normal and arthritic cartilage. J Clin Invest 50:1712-1719, 1971
3. Mochan E, Keler T: Plasmin degradation of cartilage proteoglycan. Biochim Biophys Acta 800:312-315, 1988
4. Dean DD: Proteinase-mediated cartilage degradation in osteoarthritis. Semin Arthritis Rheum 20:2-11, 1991
5. Sapolsky AI, Keiser H, Howell DS, Woessner JF: Metalloproteinases of human articular cartilage that digest cartilage proteoglycan at neutral and acid pH. J Clin Invest 58:1030-1041, 1976
6. Pelletier JP, Martel-Pelletier J, Howell DS, Ghandur-Mnaymneh L, Enis JE, Woessner JF Jr: Collagenase and collagenolytic activity in human osteoarthritic cartilage. Arthritis Rheum 26:63-68, 1983
7. Martel-Pelletier J, Pelletier JP, Cloutier JM, Howell DS, Ghandur-Mnaymneh L, Woessner JF Jr: Neutral proteases capable of proteoglycan digesting activity in osteoarthritic and normal human articular cartilage. Arthritis Rheum 27:305-312, 1984
8. Nguyen Q, Mort JS, Roughly PJ: Preferential mRNA expression of prostromelysin relative to procollagenase and in situ localization in human articular cartilage. J Clin Invest 89:1189-1197, 1992
9. Mehraban F, Kuo S-Y, Riera H, Chang C, Moskowitz RW: Prostromelysin and procollagenase genes are differentially up-regulated in chondrocytes from the knees of rabbits with experimental osteoarthritis. Arthritis Rheum 37:1189-1197, 1994
10. Mohtai M, Smith RL, Schurman DJ, Tsuji Y, Torti FM, Hutchinson NI, Stetler-Stevenson WG, Goldberg GI: Expression of 92-kD type IV collagenase/gelatinase (gelatinase B9) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin-1. J Clin Invest 92:179-185, 1993
11. Wilhelm SM, Shao ZH, Housley TJ, Seperack PK, Baumann AP, Gunja-Smith Z, Woessner JF: Matrix metalloproteinase-3 (stromelysin-1). J Biol Chem 268:21906-21913, 1993
12. Stricklin GP, Welgus HG: Human skin fibroblast collagenase inhibitor: purification and biochemical characterization. J Biol Chem 258:12252-12258, 1983
13. Steler-Stevenson WG, Krutzsch HC, Liotta LA: Tissue inhibitor of metalloproteinase (TIMP-2): a new member of the metalloproteinase inhibitor family. J Biol Chem 264:17374-17378, 1989
14. Martel-Pelletier J, McCollum R, Fujimoto N, Obata K, Cloutier JM, Pelletier JP: Excess of metalloproteinases over tissue inhibitor of metalloproteinase may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab Invest 70:807-815, 1994
15. Dean DD, Martel-Pelletier J, Pelletier JP, Howell DS, Woessner JF: Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 84:678-685, 1989
16. Lefebvre V, Peeters-Joris C, Vaes G: Modulation by interleukin-1 and tumor necrosis factor a of production of collagenase, tissue inhibitor of metalloproteinase and collagen types in differentiated and dedifferentiated articular chondrocytes. Biochim Biophys Acta 1052:366-378, 1990
17. Martel-Pelletier J, Zafarullah M, Kodama S, Pelletier JP: In vitro effects of interleukin-1 on the synthesis of metalloproteases, TIMP, plasminogen activators and inhibitors in human articular cartilage. J Rheumatol Suppl 27:80-84, 1991
18. Shinmei M, Masuda K, Kikuchi T, Shimomura Y: Interleukin-1, tumor necrosis factor, and interleukin-6 as mediators of cartilage destruction. Semin Arthritis Rheum 18 (suppl 1):27-32, 1989
19. Lotz M, Guerne PA: Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinase-1/erythroid potentiating activity (TIMP-1/EPA). J Biol Chem 266:2017-2021, 1991
20. Maier R, Ganu V, Lotz M: Interleukin-11, an inducible cytokine in human articular chondrocytes and synoviocytes, stimulates the production of tissue inhibitor of metalloproteinases. J Biol Chem 268:21527-21532, 1993
21. Günther M, Haubeck HD, van de Leue E, Blaser J, Bender S, Gutgemann I, Fischer DC, Tschesche H, Greiling H, Heinrich PC, Graeve L: Transforming growth factor β1 regulates tissue inhibitor of metalloproteinases-1 expression in differentiated human articular chondrocytes. Arthritis Rheum 37:395-405, 1994
22. Rose TM, Bruce AG: Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin-6. Proc Natl Acad Sci U S A 88:8641-8645, 1991
23. Bazan JF: Neuropoietic cytokines in the hematopoietic fold. Neuron 7:197-208, 1991
24. Ip NY, Nye SH, Boulton TG, Davis S, Taga T, Li Y, Birren SJ, Yasukawa K, Kishimoto T, Anderson DJ, Stahl N, Yancopoulos GD: CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130. Cell 69:1121-1132, 1992
25. Gearing DP, Comeau MR, Friend DJ, Gimpel SD, Thut CJ, McGourty J, Brasher KK, King JA, Gillis S, Mosley B: The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science 255:1434-1437, 1992
26. Richards CD, Shoyab M, Brown TJ, Gauldie J: Selective regulation of metalloproteinase inhibitor (TIMP-1) by oncostatin M in fibroblasts in culture. J Immunol 150:5596-5603, 1993
27. Zhang J, Fujimoto N, Iwata K, Sakai T, Okada Y, Hayakawa T: A one-step sandwich enzyme immunoassay for human matrix metaUoproteinase 1 (interstitial collagenase) using monoclonal antibodies. Clin Chim Acta 219:1-14, 1993
28. Obata K, Iwata K, Okada Y, Kohrin Y, Obuchi E, Yosida S: A one step sandwich enzyme immunoassay for human matrix metalloproteinase 3 (stromelysin-1) using monoclonal antibodies. Clin Chim Acta 211:59-72, 1992
29. Sato H, Kida Y, Mai M, Endo Y, Sasaki T, Tanaka J, Seiki M: Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene 7:77-83, 1993
30. Mankin HJ, Lipiello L: Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. J Bone Joint Surg [Am] 52:424-434, 1970
31. Kodama S, Iwata K, Iwata H, Yamashita K, Hayakawa T: Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases. J Immunol Methods 127:103-108, 1990
32. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
33. Sambrook J, Fritsch EF, Maniatis T: Extraction, purification, and analysis of messenger RNA from eukaryotic cells. In, Molecular Cloning. Vol. 1. Edited by J Sambrook, EF Fritsch, T Maniatis. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1989
34. Zarling JM, Shoyab M, Marquardt H, Hanson MB, Lioubin MN, Todaro GJ: Oncostatin M: a growth regulator produced by differentiated histiocyte lymphoma cells. Proc Nat Acad Sci U S A 83:9739-9744, 1986
35. Horn D, Fitzpatrick WC, Gompper PT, Ochs V, Bolton-Hanson M, Zarling J, Malik N, Todaro Gj, Linsley PS: Regulation of cell growth by recombinant oncostatin M. Growth Factors 2:157-165, 1990
36. Brown TJ, Rowe JM, Liu JW, Shoyab M: Regulation of IL-6 expression by oncostatin M. J Immunol 147:2175-2180, 1991
37. Grove RI, Mazzucco CE, Radka SF, Shoyab M, Kiener PA: Oncostatin M up-regulates low density lipoprotein receptor in HepG2 cells by a novel mechanism. J Biol Chem 266:18194-18199, 1991
38. Hamilton JA, Leizer T, Piccoli DS, Royston KM, Butler DM, Croatto M: Oncostatin M stimulates urokinase-type plasminogen activator activity in human synovial fibroblasts. Biochem Biophys Res Commun 180:652-663, 1991
39. Davis S, Aldrich TH, Stahl N, Taga T, Kishimoto T, Ip NY, Yancopoulos GD: LIFR beta and gp130 as heterodimerizing signal transducers of the triparite CNTF receptor. Science 260:1805-1808, 1993
40. Guerne PA, Lotz M: Interleukin-6 and transforming growth factor-β synergistically stimulate chondrosarcoma cell proliferation. J Cell Physiol 149:117-124, 1991
41. Chandrasekhar S, Harvey AK: Transforming growth factor-β is a potent inhibitor of IL-1 induced protease activity and cartilage proteoglycan degradation. Biochem Biophys Res Commun 157: 1352-1359, 1988
42. Van Beuningen HM, van der Kraan PM, Arntz QJ, van den Berg WB: Protection from interleukin-1 induced destruction of articular cartilage by transforming growth factor β: studies in anatomically intact cartilage in vitro and in vivo. Ann Rheum Dis 52:185-191, 1993